Atypical hemolytic uremic syndrome: diagnosis, management, and discontinuation of therapy

Hematology (United States) · Published 2024-12-06 · DOI 10.1182/hematology.2024000543

Authors being retrieved — see the publisher record. https://doi.org/10.1182/hematology.2024000543

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2024

Related articles

• Nursing care of an infant with atypical hemolytic uremic syndrome complicated by spontaneous bullous rupture and dystrophic wound calcification: A case report · Journal of Pediatric Nursing · 2026 · Cites or is cited by this article
• Advances in the diagnosis and management of pediatric Langerhans cell histiocytosis and Rosai-Dorfman disease: therapies, biomarkers, and response assessment · Hematology (United States) · 2025 · Same journal
• From treatment to biology and back: managing iron overload in transfused hemoglobinopathies · Hematology (United States) · 2025 · Same journal
• What's new in hereditary hemorrhagic telangiectasia? · Hematology (United States) · 2025 · Same journal
• Hemophagocytic lymphohistiocytosis: do we have a solution for TMI (too much inflammation)? · Hematology (United States) · 2025 · Same journal
• The right patient, the right treatment: tailoring sickle cell disease care · Hematology (United States) · 2025 · Same journal
• How to approach the high-risk myeloma from induction through relapse? · Hematology (United States) · 2025 · Same journal
• Management of iron overload in adult myelodysplastic syndrome · Hematology (United States) · 2025 · Same journal
• When sickle cell trait is not just trait: risk of VTE · Hematology (United States) · 2025 · Same journal
• Optimizing the “right” patient selection for treatment for sickle cell disease · Hematology (United States) · 2025 · Same journal